Keywords: Transatlantic trade, Economy, Regulation, Intellectual property, Anti-counterfeiting, Eli Lilly

Biopharma should be part of transatlantic trade and economic discussions, Lilly CEO urges

Article | 12 July 2011

Print This

John Lechleiter, chairman, president and chief executive of US drugs major Eli Lilly (NYSE: LSE) has urged that biopharmaceuticals be ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in